Strategic Partners Target Alphazyme as a gateway to collaborations with nucleic acid therapies and detection platform manufacturers, leveraging their role as a trusted enzyme development and production partner to expand co-development and contract manufacturing opportunities.

Scale and GMP-readiness Position to offer scalable enzyme production and GMP-compliant processes, highlighting Alphazyme’s focus on consistent quality and regulatory compatibility to support clients aiming for industrial-scale manufacturing of DNA and RNA enzymes.

New Enzyme Offerings Leverage the launch of CleanScribe RNA Polymerase and potential dsRNA-reduction benefits to identify customers needing cleaner IVT transcripts for mRNA therapeutics, vaccines, and research applications.

Strategic Acquisitions Explore cross-sell opportunities with Maravai LifeSciences subsidiaries and related entities acquired or partnered with Alphazyme, offering integrated enzyme solutions across broader life sciences workflows.

Quality and Compliance Emphasize high-quality eQMS and quality leadership to enterprise buyers seeking reliable vendor oversight, regulatory alignment, and traceable manufacturing records for regulated biotech programs.